All Q2 FY26 results →
JL

Jyothy Labs Ltd

Q2 FY26Household Products

Jyothy Labs Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹190
Market cap₹7.0K Cr
P/E24.5
Updated16 Oct 2026
Read5 min read

The short version

Jyothy Labs aims to achieve double-digit volume growth by the exit of FY'26, driven by positive early demand signals and broad-based consumption recovery. Jyothy Labs aims to return to double-digit volume growth by the exit of FY'26, supported by new product launches and improved market conditions. - Operating EBITDA margin is expected to be maintained in the 16%-17% range in H2 FY'26, assuming stable commodity prices and improving demand. - Personal care segment margins, currently affected by GST related disruptions and input costs, are expected to revert back to double-digit EBIT margins in the next few quarters. - Home insecticide segment is targeted to turn profitable within 4-6 quarters, focusing on liquid vaporizers and new profitable formats like aerosols and mosquito rackets. - The company remains focused on organic profitable growth with investments in innovation and brand building, while also selectively considering inorganic growth (M&A) to accelerate expansion. - Net cash generation and strong cash balance (Rs.

From Jyothy Labs Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Jyothy Labs aims to achieve double-digit volume growth by the exit of FY'26, driven by positive early demand signals and broad-based consumption recovery.
  • Value growth is expected to trail volume growth by approximately 2%-2.5% due to lower average realizations and market pricing dynamics.
  • The company anticipates steady broad-based growth in the second half of FY'26 across key segments like Fabric Care and Dish Wash.
  • New product launches such as Jovia and Margo Neem Naturals are expected to contribute significantly, with improvements starting from Q3 onwards.

2 more points from Jyothy Labs Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Jyothy Labs Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Jyothy Labs is actively looking for the right asset to complement its existing portfolio, focusing on both organic growth and inorganic opportunities (Page 7).
  • The company has explored and is in talks with a few businesses for potential acquisitions; specifics will be disclosed once materialized (Page 7).
  • With a strong cash balance of Rs. 801 crore and zero debt, Jyothy Labs is well-positioned to fund growth and invest in innovation (Page 5).

2 more points from Jyothy Labs Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Household Products

Ranked on what management guided this quarter

Guidance-ranked
1DOMS Industries
Rev 3Mar 3
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 4Mar 3
Sign up free to see 2 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Jyothy Labs Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript and report for Jyothy Labs Limited's Q2 FY'26 earnings call do not mention any specific details regarding the current or expected order book or pending orders. Key points from the document related to sales and operations are: - Revenue from operations for Q2 FY'26 was Rs. 736 crore with 0.4% value growth and 2.8% volume growth. - The company experienced short-term disruption due to GST rate revision affecting personal care products. - Demand signals are encouraging as Q3 has started, with modern trade, e-commerce, and quick commerce channels growing well.

2 more points from Jyothy Labs Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Jyothy Labs Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹717 Cr, net profit ₹68 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Household Products this season

  • DOMS Industries Ltd (Q2 FY26)

    Revenue growth mainly driven by volume increases, with minimal impact from price hikes (2-3%). Key concall takeaways from DOMS Industries Ltd's Q2 FY26…

  • Flair Writing Industries Ltd (Q2 FY26)

    Creative segment: Rapid growth with 70% YoY increase in Q2 FY '26; expanding product portfolio (237 products) and distribution; growth momentum to continue…

  • Navneet Education Ltd (Q2 FY26)

    Non-paper stationery volumes to increase at least 100% annually for the next 3 years. Key concall takeaways from Navneet Education Ltd's Q2 FY26 earnings call…

  • Eveready Industries India Ltd (Q2 FY26)

    Strong revenue growth in battery and lighting categories with a 6.7% quarter-on-quarter increase. Key concall takeaways from Eveready Inds.'s Q2 FY26 earnings…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Jyothy Labs Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Jyothy Labs Ltd Q2 FY26 results?

Jyothy Labs aims to achieve double-digit volume growth by the exit of FY'26, driven by positive early demand signals and broad-based consumption recovery. Jyothy Labs aims to return to double-digit volume growth by the exit of FY'26, supported by new product launches and improved market conditions. - Operating EBITDA margin is expected to be maintained in the 16%-17% range in H2 FY'26, assuming stable commodity prices and improving demand. - Personal care segment margins, currently affected by GST related disruptions and input costs, are expected to revert back to double-digit EBIT margins in the next few quarters. - Home insecticide segment is targeted to turn profitable within 4-6 quarters, focusing on liquid vaporizers and new profitable formats like aerosols and mosquito rackets. - The company remains focused on organic profitable growth with investments in innovation and brand building, while also selectively considering inorganic growth (M&A) to accelerate expansion. - Net cash generation and strong cash balance (Rs.

What is Jyothy Labs Ltd share price analysis?

Jyothy Labs Ltd currently shows a neutral. The stock trades at a P/E of 24.5 with a market cap of ₹6,968 Cr. Investors should review the full earnings analysis for detailed insights.

Is Jyothy Labs Ltd planning capital expenditure?

Jyothy Labs is actively looking for the right asset to complement its existing portfolio, focusing on both organic growth and inorganic opportunities (Page 7). - The company has explored and is in talks with a few businesses for potential acquisitions; specifics will be disclosed once materialized (Page 7). - With a strong cash balance of Rs.

Keep Jyothy Labs Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.